Search

everythinglearnresearchcommunity

for

Search:↓

The oral testosterone effectively increased testosterone levels and reduced SHBG, showing promise for treating testosterone deficiency.

A new hair loss treatment with two unique ingredients improved hair growth.

Astraglus polysaccharide may help hair growth by boosting follicle stem cell activity.

High-dose androgen therapy can help manage certain types of androgen resistance.

AMP-303 safely increases hair growth in men with hair loss.

Normal levels for certain hormones in Chinese women of reproductive age were identified.

Cholesterol helps hair grow by activating nerves and boosting hair follicle stem cells.

A humanized IL-2 fusion protein boosts T regulatory cells and helps control hair loss in Alopecia Areata.

Surgical removal of a rare ovarian tumor improved symptoms and hormone levels in a postmenopausal woman.

Measuring 17-hydroxyprogesterone in hair can help monitor androgen levels in people with congenital adrenal hyperplasia.

TGF-alpha is present in sheep and ferret skin and may affect hair growth without directly stimulating cell proliferation.

The Rigenera method improved hair thickness and reduced hair loss in patients.

Inositol and folic acid treatment significantly reduced hair loss and other symptoms in patients with androgenetic alopecia, but more research is needed for confirmation.

A woman's high testosterone levels and related symptoms improved after ovary removal surgery.

Girls conceived via assisted reproductive technologies show early puberty signs and larger ovaries.

New treatment improves male hair loss.

HDAC6 helps keep ovarian follicles dormant, extending female fertility.

Dutasteride is more effective than finasteride for hair loss, but more research is needed on safety and dosing.

Topical 17 alpha-propylmesterolone increases hair cell growth in androgenetic alopecia.

Overexpression of PTHrP in chondrocytes causes short-limbed dwarfism and delayed bone formation in mice.

Non-classical 21 hydroxylase deficiency is an underdiagnosed cause of female hair loss and polycystic ovarian syndrome.

DHT enhances androgen receptor activity more than testosterone, and MAGE-11 influences this activity through specific interactions.

The document concludes that a systematic approach is crucial to identify causes of androgen excess in women beyond the most common cause, Polycystic ovary syndrome (PCOS).

Hormone therapy improves mental well-being in transgender individuals but requires ongoing health monitoring.

The new model mimics hair loss and helps test treatments.

Combining flutamide and finasteride can reduce prostate weight and tumor growth, potentially benefiting treatments needing optimal DHT inhibition.

Hormonal therapies like cyproterone acetate and spironolactone may help some women with hair loss, but finasteride 1mg is not useful, and the effectiveness of other treatments is still unclear.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

The combination of arginine and zinc reduces hair loss and increases hair growth effectively.